Corcept Therapeutics | CORT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Ardelyx USD 109.57M 20.96M 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
J&J USD 54.9B 2.82B 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Merck USD 27.73B 786M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 31.75B 374M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06